Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX

To investigate intercenter agreement of brain volume (change) measurement in multiple sclerosis (MS) using structural image evaluation using normalization of atrophy (SIENA) and the cross‐sectional version of SIENA (SIENAX) with additional manual editing to correct for inadequate brain extraction.

[1]  M. Battaglini,et al.  Response to the letter “Progression of gray matter atrophy and its association with white matter lesions in relapsing–remitting multiple sclerosis” by Bendfeldt et al. , 2009, Journal of the Neurological Sciences.

[2]  A Giorgio,et al.  Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis , 2009, Neurology.

[3]  Marco Battaglini,et al.  Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis , 2009, Journal of the Neurological Sciences.

[4]  A. Giorgio,et al.  Impairment of vertical saccades from an acute pontine lesion in multiple sclerosis. , 2008, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[5]  Heidi Johansen-Berg,et al.  Imaging white matter diffusion changes with development and recovery from brain injury , 2008, Developmental neurorehabilitation.

[6]  Frederik Barkhof,et al.  Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. , 2007, Archives of neurology.

[7]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[8]  M Rovaris,et al.  Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis , 2004, Neurology.

[9]  Lluís Jover,et al.  Estimating the Generalized Concordance Correlation Coefficient through Variance Components , 2003, Biometrics.

[10]  Michael R. Chernick,et al.  Tests of Hypotheses , 2003 .

[11]  J H Simon,et al.  Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.

[12]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[13]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[14]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.

[15]  Marco Rovaris,et al.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.

[16]  Massimo Filippi,et al.  European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.

[17]  F. Barkhof,et al.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.

[18]  A J Thompson,et al.  Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis , 1995, Neurology.